The state invested huge capital to support new drugs to develop a number of pharmaceutical companies or benefit
Release time: 2011-09-22 & nbsp & nbsp & nbsp Source:
Business Club, September stake online sports bettingstake online sports betting20th According to authoritatives，The State will arrange billions of yuan for special funds to support the development of new drugs，Related companies will be shortlisted by applying for topics。According to requirements，New drugs that are shortlisted must have broad market development prospects，It can solve the problem of preventing and controlling the most urgent major diseases at present。
Public information display，Announcement disclosed by Hengrui Medicine on June 15th，The national first -class new drug "Eripo Film and Raw Materials" developed by the company's "New Medicine Certificate" and "Drug Registration Approval" issued by the State Drug Administration，13181_13200，The announcement stated that the drug was mainly used to relieve the pain symptoms of osteoarthritis，The market development prospect is good; the anti -cancer drugs owned stake sports betting appstake online sports bettingby Laimei Pharmaceuticals have obtained the major special project of the "Eleventh Five -Year Plan" major new drug creation technology，and get a national financial allocation of 1.42 million yuan，This shortlisted rolling support topic is more likely; Huashen Group's 2011 semi -annual report disclosure，The treatment of primary liver cancer for the treatment of primary liver cancer has entered the clinical phase IV，Subsequent cooperation with scientific research projects、The method of co -building ward together with the key medicine of liver cancer treatment in various places to promote the "Licatin Clinical Research and Development Center"、Construction of "Licatin Treatment Center"，Due to the lack of effective primary liver cancer medicine in China，The market is urgent for the drug; Aizheng Pharmaceutical Anti -tumor's large variety drugs My stake betting appstake online sports bettingAimicin is a best -selling anticancer drug in the international and domestic market，There is further improvement of production capacity and market scale。
Analysts point out，All kinds of new drugs owned by the above company are in accordance with the regulations of new drug research and development projects supported by the national key，Possibility of shortlishes is more likely。If selected，Can obtain support for national special funds，At the same time, the brand image is also established，It is conducive to the company's follow -up market development。(Liu Zhongcai)
Public information display，Announcement disclosed by Hengrui Medicine on June 15th，The national first -class new drug "Eripo Film and Raw Materials" developed by the company's "New Medicine Certificate" and "Drug Registration Approval" issued by the State Drug Administration，13181_13200，The announcement stated that the drug was mainly used to relieve the pain symptoms of osteoarthritis，The market development prospect is good; the anti -cancer drugs owned stake sports betting appstake online sports bettingby Laimei Pharmaceuticals have obtained the major special project of the "Eleventh Five -Year Plan" major new drug creation technology，and get a national financial allocation of 1.42 million yuan，This shortlisted rolling support topic is more likely; Huashen Group's 2011 semi -annual report disclosure，The treatment of primary liver cancer for the treatment of primary liver cancer has entered the clinical phase IV，Subsequent cooperation with scientific research projects、The method of co -building ward together with the key medicine of liver cancer treatment in various places to promote the "Licatin Clinical Research and Development Center"、Construction of "Licatin Treatment Center"，Due to the lack of effective primary liver cancer medicine in China，The market is urgent for the drug; Aizheng Pharmaceutical Anti -tumor's large variety drugs My stake betting appstake online sports bettingAimicin is a best -selling anticancer drug in the international and domestic market，There is further improvement of production capacity and market scale。
Analysts point out，All kinds of new drugs owned by the above company are in accordance with the regulations of new drug research and development projects supported by the national key，Possibility of shortlishes is more likely。If selected，Can obtain support for national special funds，At the same time, the brand image is also established，It is conducive to the company's follow -up market development。(Liu Zhongcai)
